Email:
michaelhsiung@arkpharmtech.com
po@arkpharmtech.com
|
| Product Name | N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluoro-3-hydroxyphenyl)cyclopropane-1,1-dicarboxamide |
| Synonyms | Cabozantinib impurity 66;F5HE6AB5AL;Cabozantinib metabolite M13;BDBM381928;US10273211, Compound 13;1,1-Cyclopropanedicarboxamide, N-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(4-fluoro-3-hydroxyphenyl)-;N-(4-((6,7-Dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide;Unii-F5HE6AB5AL |
| Catalog No. | H-047446 |
| CAS No. | 1628530-41-5 |
| Molecular Formula | C28H24FN3O6 |
| Molecular Weight | 517.5051 |
| Smile Code | O=C(C1(C(N)=O)CC1)N(C2=CC=C(OC3=CC=NC4=CC(OC)=C(OC)C=C34)C=C2)C5=CC=C(F)C(O)=C5 |
| InChI | |
| EINECS | |
| Density | |
| Melting point | |
| Boiling point | |
| Refractive index | |
| Water solubility | |
| Hazard Symbols | |
| Risk Codes | |
| Safety Description |